123 related articles for article (PubMed ID: 6799199)
1. Hexamethylmelamine distribution in patients with ovarian and other pelvic cancers.
D'Incalci M; Farina P; Sessa C; Mangioni C; Garattini S
Cancer Treat Rep; 1982 Feb; 66(2):231-5. PubMed ID: 6799199
[TBL] [Abstract][Full Text] [Related]
2. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M; Rossi C; Colombo T; D'Incalci M
Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
[TBL] [Abstract][Full Text] [Related]
4. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
Klippert PJ; Hulshoff A; Mingels MJ; Hofman G; Noordhoek J
Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
[TBL] [Abstract][Full Text] [Related]
5. Variable oral absorption of hexamethylmelamine in man.
D'Incalci M; Bolis G; Mangioni C; Morasca L; Garattini S
Cancer Treat Rep; 1978 Dec; 62(12):2117-9. PubMed ID: 109196
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
Gordon IL; Kar R; Opfell RW; Wile AG
Cancer Res; 1987 Oct; 47(19):5070-3. PubMed ID: 3113728
[TBL] [Abstract][Full Text] [Related]
7. Influence of ascites on the pharmacokinetics of hexamethylmelamine and N-demethylated metabolites in ovarian cancer patients.
D'Incalci M; Beggiolin G; Sessa C; Mangioni C
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1331-5. PubMed ID: 6802647
[No Abstract] [Full Text] [Related]
8. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
Paolini A; D'Incalci M
Cancer Treat Rep; 1986 Apr; 70(4):513-6. PubMed ID: 3084083
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
Ames MM; Powis G; Kovach JS; Eagan RT
Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
[TBL] [Abstract][Full Text] [Related]
10. Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.
Garattini E; Colombo T; Donelli MG; Catalani P; Bianchi M; D'Incalci M; Pantarotto C
Cancer Chemother Pharmacol; 1983; 11(1):51-5. PubMed ID: 6411375
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicle.
Wickes AD; Howell SB
Cancer Treat Rep; 1985 Jun; 69(6):657-62. PubMed ID: 3926309
[TBL] [Abstract][Full Text] [Related]
12. Hexamethylmelamine/altretamine as second-line therapy for epithelial ovarian carcinoma.
Moore DH; Valea F; Crumpler LS; Fowler WC
Gynecol Oncol; 1993 Oct; 51(1):109-12. PubMed ID: 8244164
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamine.
Brindley C; Gescher A; Langdon SP; Broggini M; Colombo T; D'Incalci M
Biochem Pharmacol; 1982 Mar; 31(5):625-31. PubMed ID: 6805472
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.
Garattini E; Donelli MG; Colombo T; Paesani R; Pantarotto C
Biochem Pharmacol; 1981 May; 30(10):1151-4. PubMed ID: 6789835
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administration.
Dubois J; Atassi G; Hanocq M; Abikhalil F
Cancer Chemother Pharmacol; 1986; 18(3):226-30. PubMed ID: 3100080
[TBL] [Abstract][Full Text] [Related]
16. A sensitive and specific assay for pentamethylmelamine in plasma: applicability to clinical studies.
Dutcher JS; Jones RB; Boyd MR
Cancer Treat Rep; 1980 Jan; 64(1):99-104. PubMed ID: 6769585
[TBL] [Abstract][Full Text] [Related]
17. Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.
Boven E; Nauta MM; Schlüper HM; Erkelens CA; Pinedo HM
Cancer Chemother Pharmacol; 1986; 18(2):124-8. PubMed ID: 3098444
[TBL] [Abstract][Full Text] [Related]
18. Determination of hexamethylmelamine and metabolites in plasma or serum by gas-liquid chromatography with a nitrogen-sensitive detector.
Hulshoff A; Neijt JP; Smulders CF; van Loenen AC; Pinedo HM
J Chromatogr; 1980 Mar; 181(3-4):363-71. PubMed ID: 6771300
[TBL] [Abstract][Full Text] [Related]
19. Hexamethylmelamine tissue concentrations in pelvic cancer patients.
D'Incalci M; Farina P; Sessa C; Erba E; Madonna R; Mangioni C
Ther Drug Monit; 1980; 2(2):187-8. PubMed ID: 6820202
[No Abstract] [Full Text] [Related]
20. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
